CBRN Decontamination Industry Outlook - 2007-2012

Table of Contents

1. Scope

• 1.1. Definition of Decontamination
• 1.2. Scope of this Report
• 1.3. Basic Assumptions
  • 1.3.1. General
  • 1.3.2. Why is Stockpiling Decontamination Solutions Needed?
  • 1.3.3. Possible Scenario Analysis
• 1.4. Methodology
  • 1.4.1. Research Methods
  • 1.4.2. Report Structure
• 1.5. Who is this Report for?

2. Executive Summary

• 2.1. Main Conclusions
• 2.2. The Threat of CBRN Terrorism
• 2.3. How Real is the Threat?
• 2.4. Decontaminating After a CBRN Event
• 2.5. Decontamination - the Industry
• 2.6. Decontamination Market Forecast - 2007-2012
• 2.7. Challenges for Next Generation Decontamination Technologies

3. Decontamination - Industry Drivers

4. Decontamination - Industry Inhibitors

5. The Threat of CBRN Warfare

• 5.1. The Threat of Biological Terror
  • 5.1.1. Use of Bio-Weapons - Historical Perspective
  • 5.1.2. Biological Terror - Bacterial Agents
  • 5.1.3. Biological Terror - Viral Agents
  • 5.1.4. Biological Terror - Rickettsiae Agents
  • 5.1.5. Biological Terror - Toxins
• 5.2. The Threat of Nuclear Radiological Terror
  • 5.2.1. How Real is the Nuclear Threat?
  • 5.2.2. Nuclear Terror
  • 5.2.3. A Radiological Dispersal Device (RDD)
• 5.3. The Threat of Chemical Terror
  • 5.3.1. Nerve Agents
  • 5.3.2. Blister Agents

6. Decontamination - Technological and System Requirements

• 6.1. Defining the Problem
• 6.2. Stages of a Decontamination Process
  • 6.2.1. Contaminant Identification
  • 6.2.2. Sample Characterization
  • 6.2.3. Isolation of Contaminated Area
  • 6.2.4. Design of Decontamination Strategy
  • 6.2.5. Decontamination
  • 6.2.6. Clearance Sampling
• 6.3. Performance Limitations
  • 6.3.1. Limit 1 - Time
  • 6.3.2. Limit 2 - How Clean is Clean
  • 6.3.3. Limit 3 - Lack of Accurate Contamination Simulations Scenarios
  • 6.3.4. Limit 4 - Cost
  • 6.3.5. Limit 5 - Environmentally Unfriendly Materials
  • 6.3.6. Limit 6 - Transport and Storage Limitations
  • 6.3.7. Limit 7 - Inability to Handle Radioactive Contamination
• 6.4. Decontamination Core Technologies Overview
• 6.5. Physics-Based Decontamination Core Technologies
  • 6.5.1. Sorbents
  • 6.5.2. Solvent-Wash
  • 6.5.3. High-Pressure Methods
  • 6.5.4. Thermal Methods
• 6.6. Chemistry-based Decontamination Core Technologies
  • 6.6.1. Oxidizing Agents
  • 6.6.2. Strong Bases
  • 6.6.3. Surfactants
  • 6.6.4. Microemulsions
• 6.7. Biology-Based Core Technologies
  • 6.7.1. Bacterial Decontamination Agents
  • 6.7.2. Enzymatic Systems
• 6.8. Decontamination System Configurations
  • 6.8.1. Application 1 - People Decontamination Systems
  • 6.8.2. Application 2 - Equipment Decontamination Systems
  • 6.8.3. Application 3 - Building and Infrastructure Decontamination Systems
• 6.9. New Technologies Drivers
• 6.10. New Technologies Inhibitors

7.Business Opportunities - 2007-2012

• 7.1. Historical Perspective: A Market Waiting for Transition
  • 7.1.1. The Current and Future HLS Decontamination Strategy
  • 7.1.2. Factors Affecting Decontamination Systems Business Opportunities and Technologies - 2007-2012
• 7.2. Business Opportunities for Decontamination Systems
  • 7.2.1. Business Opportunity 1 - New Technologies to Counter Radiological Contamination
  • 7.2.2. Business Opportunity 2 - Non-Toxic/Environmentally Friendly Biological-Agents Decontamination Technology
  • 7.2.3. Business Opportunity 3 - Improving Contamination Simulation Capability
  • 7.2.4. Business Opportunity 4 - Improving Biological Sampling Accuracy
  • 7.2.5. Business Opportunity 5 - Decontamination Standards
  • 7.2.6. Business Opportunity 6 - Reducing Decontamination Time
  • 7.2.7. Business Opportunity 7 - Reducing Cost of Reagents / Decontamination Material
• 7.3. Radiological Decontamination Technologies
  • 7.3.1. Business Opportunity 8 - Concrete-Eating Bacteria
  • 7.3.2. Business Opportunity 9 - Decontamination Foams
  • 7.3.3. Business Opportunity 10 - Nano-Particle Super-Absorbent Gels
  • 7.3.4. Business Opportunity 11 - Strippable coatings
  • 7.3.5. Business Opportunity 12 - Electro-Kinetic Concrete Cleaning
• 7.4. Chemical-Biological Decontamination Technologies and Business Opportunities
  • 7.4.1. Business Opportunity 13 - Forced Hot Air Systems
  • 7.4.2. Business Opportunity 14 - Modified Vaporous Hydrogen Peroxide
  • 7.4.3. Business Opportunity 15 - Decon Green
  • 7.4.4. Business Opportunity 16 - Resistant/Reactive Coatings
  • 7.4.5. Business Opportunity 17 - Enzyme Decontamination
  • 7.4.6. Business Opportunity 18 - Ionic-Liquid-based Decontamination
  • 7.4.7. Business Opportunity 19 - Supercritical Carbon Dioxide Decontamination
  • 7.4.8. Business Opportunity 20 - Electrostatic Decontamination System
  • 7.4.9. Business Opportunity 21 - Atmospheric Plasma Decontamination
• 7.5. Contamination Simulation Algorithms
  • 7.5.1. Business Opportunity 22 - Vulnerability of Building to CBRN Attack Algorithms

8. Decontamination - U. S. Federal HLS R&D Programs and Funding Opportunities Forecast - 2007-2012

• 8.1. Summary & Outlook
• 8.2. Decontamination - U. S. Federal HLS R&D Funding Opportunities by Major Departments Forecast - 2007-2012
  • 8.2.1. EPA - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.2. DOD - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.3. DHS - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.4. DOE - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.5. TSWG - Decontamination HLS R&D Budget Forecast - 2007-2012
• 8.3. Decontamination - U. S. Federal HLS R&D Funding Opportunities Forecast - 2007-2012
• 8.4. Decontamination - U. S. Federal HLS Pharmaceuticals R&D Funding Opportunities Drivers - 2007-2012
• 8.5. Decontamination - U. S. Federal HLS R&D Funding Opportunities Inhibitors - 2007-2012
• 8.6. DHS - Decontamination HLS R&D Programs
  • 8.6.1. Response and Recovery
  • 8.6.2. Decontamination of Porous Surfaces After a Radiological Attack
  • 8.6.3. Expedient Mitigation of a Radiological Release
• 8.7. DARPA (DOD) - Decontamination HLS R&D Programs
  • 8.7.1. Immune Buildings
  • 8.7.2. External Protection
• 8.8. CBDP (DOD) - Decontamination HLS R&D Programs
  • 8.8.1. Project CB1 - Decontamination
  • 8.8.2. Project CB2 - Decontamination
  • 8.8.3. Project CB3 Biological Defense (ATD) - Decontamination
  • 8.8.4. Project DE4 Decontamination Systems (ACD&P)
  • 8.8.5. Project DE5 Decontamination Systems (SDD)
• 8.9. ARMY (DOD) - Decontamination HLS R&D Programs
  • 8.9.1. Environmental Quality Technology
• 8.10. DOE - Decontamination HLS R&D Programs
  • 8.10.1. Environmental Remediation Science Research
• 8.11. EPA - Decontamination HLS R&D Programs
  • 8.11.1. Water Infrastructure Decontamination
  • 8.11.2. Threat and Consequence Assessment
  • 8.11.3. Nonstandard Methods
  • 8.11.4. Decontamination for Buildings, Large Structures, and Outdoor Areas
  • 8.11.5. Toxicity, Infectivity, and Mechanism of Action
• 8.12. TSWG - Decontamination HLS R&D Programs
  • 8.12.1. Statistical Design Tool for Sampling Contaminated Buildings
  • 8.12.2. Decontamination

9. Vendors

• 9.1. Vendors and Products

10. Patent Review

• 10.1. Scope
• 10.2. Decontamination Technology Patents

11. Decontamination - Legal Issues

• 11.1. International / European Legislation/Agreements
  • 11.1.1. The Nuclear Weapons Non-Proliferation Treaty (NPT) - 1970
  • 11.1.2. The Biological and Toxin Weapons Convention (BTWC) - 1972
  • 11.1.3. Convention for the Physical Protection of Nuclear Material - 1987
  • 11.1.4. Chemicals Weapons Convention - 1992
• 11.2. U.S. Legislation
  • 11.2.1. U.S. Code Title 50, Chapter 40 - Defense Against Weapons of Mass Destruction
  • 11.2.2. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - 1996
  • 11.2.3. Emergency Supplemental Appropriations Act for Recovery from and Response to Terrorist Attacks on the United States - 2001
  • 11.2.4. Public Health Security and Bioterrorism Preparedness and Response Act - 2002